logo

Trillium Therapeutics Inc. (TRIL)



Trade TRIL now with
  Date
  Headline
8/23/2021 6:48:39 AM Pfizer To Acquire Trillium Therapeutics For An Implied Equity Value Of $2.26 Bln Or $18.50/Shr Cash
6/29/2021 7:14:52 AM Trillium Therapeutics Doses First Patient In Phase 1b/2 Study Of TTI-621 With Doxorubicin In Leiomyosarcoma
9/10/2020 10:13:17 PM Trillium Therapeutics Prices Public Offering Of 10 Mln Shares At US$13.00/shr
4/8/2020 7:15:36 AM Trillium Therapeutics Suspends Business Travel And Implements Work-from-home Policy For All Employees Due To COVID-19
3/10/2020 7:19:17 AM Trillium Therapeutics FY Loss Per Share $1.65 Vs Loss $2.35 Last Year
2/7/2020 7:17:32 AM Trillium Therapeutics Names Paul Walker To Board Of Directors
1/7/2020 8:37:23 AM Trillium Provides Update On Its TTI-621 And TTI-622 Clinical Programs